Leonteq Securities’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Other funds holding TARS
Leonteq Securities's TARS Position: Q3 2026 in Review
Leonteq Securities held its Tarsus Pharmaceuticals (TARS) position steady in Q3 2026 at 2,000 shares worth $157K. The position accounts for 0.01% of the portfolio, ranked #559.
Leonteq Securities first reported a position in TARS in Q3 2025 and has held it in 5 quarters since. The position peaked at $386K in Q3 2025. 247 funds tracked by Wall St. Rank hold TARS as of Q3 2026.
- Leonteq Securities held 2,000 shares of Tarsus Pharmaceuticals worth $157K as of Q3 2026.
- Leonteq Securities left its Tarsus Pharmaceuticals share count unchanged in Q3 2026.
- Tarsus Pharmaceuticals made up 0.01% of Leonteq Securities's portfolio in Q3 2026, its #559 holding.
- Leonteq Securities first reported a position in Tarsus Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- Leonteq Securities's Tarsus Pharmaceuticals position peaked at $386K in Q3 2025.
- 247 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.